Previous 10 | Next 10 |
FN Media Group Presents Oilprice.com Market Commentary London – October 19, 2021 – According to Google’s Health boss David Feinberg… over one billion people a day search Google for health concerns. But, what if, instead… they could “...
Resmed (NYSE: RMD) , Walgreens Boots Alliance (NASDAQ: WBA) and AbbVie (NYSE: ABBV) are profitable companies that have clear paths to future revenue growth. ResMed is already an industry leader in sleep apnea therapies, an area that's expected to grow as our popu...
Progenity (PROG +30.4%), which has been a laggard since the beginning of the year, has seen its fortunes change after it was recently granted patents related to its ingestible therapeutics technology. One of those patents involves delivering Pfizer's (PFE -0.2%) JAK inhibitor Xeljanz (tofacti...
Abbott Labs has dipped from its recent highs near $130 and presents a buying opportunity under $120. With a respectable and growing dividend and years of solid performance, Abbott is a good value. The entire healthcare sector has taken a beating in 2021, but this too shall pass. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors fearful of a stock market correction currently playing out for October should accumulate blue-chip stocks. The market downturn is long overdue. October may have seasonal weakness, thanks to epic crashes like the o...
In a world where bank accounts pay low interest rates, dividend-paying stocks become a more appealing avenue for retiree income. Admittedly, the average cash yield for dividend stocks in the S&P 500 is only 1.3%, and companies can theoretically end payouts anytime. Such conditions m...
This Buffett holdings list from Kiplinger first appeared 8/17/21 online. YCharts and Dogs of The Dow also track this Buffett/Berkshire Batch. Here is your update from 10/13/21 YCharts data. 29 of 44 current Berkshire-Hathaway-owned stocks pay dividends. As of 10/13/21 the top-ten rang...
The market is well aware of the Humira situation. Humira makes up the largest slice of AbbVie's revenues and profits and will be impacted hard by competition in 2023. It seems, however, that some ancillary effects might make things harder still than they seem, bringing uncertainty...
For high yield hunters, market corrections are an opportunity to enhance their income stream. Dividend payments from quality companies are largely immune to short-term market volatility. Three picks that you can buy cheap today; yields up to 10.3%. "If you don't find a way to ...
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU) - CHMP positive opinion is based on data from two Phase 3 studies, KEEPsAKE-1 and KEEPsAKE-2[1],[2] - If approved, th...
News, Short Squeeze, Breakout and More Instantly...
Thursday, AbbVie Inc (NASDAQ:ABBV) released topline results from LEVEL UP, an open-label, efficacy assessor-blinded head-to-head Pha...
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study PR Newswire Upadacitinib demonstrated superiority versus dupilumab in primary...
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands PR Newswire Consumers Can Apply for a Chance to Be Featured in Upcoming Campaigns for BOTOX ® Cosmetic, the JUVÉDERM ® ...